ArticleFrontiers in oncology2025

MYO1G promoter hypomethylation correlates with its mRNA expression, lymphocyte infiltration, and immunotherapy response in melanoma.

Yonghua Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.